UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2014, Cambridge companions to philosophy., ISBN 1107656710, xiii, 387
Book
1994, ISBN 0485113937, 3 v. (xvii, 1616 p.)
Book
1935, [8] p. port.
Book
2001, Statistics for engineering and information science., ISBN 9780387951461, xxvii, 581
Book
The New England journal of medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 27, pp. 2608 - 2617
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | Drug Resistance, Viral | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Hepatitis C, Chronic - complications | Young Adult | Heterocyclic Compounds, 4 or More Rings - therapeutic use | Aged, 80 and over | Adult | Female | Sofosbuvir - adverse effects | Sofosbuvir - therapeutic use | Liver Cirrhosis - drug therapy | Liver Cirrhosis - etiology | Antiviral Agents - therapeutic use | Genotype | Heterocyclic Compounds, 4 or More Rings - adverse effects | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - adverse effects | Carbamates - adverse effects | Aged | Carbamates - therapeutic use | Viral Nonstructural Proteins - antagonists & inhibitors | Drug Combinations | Clinical trials | Usage | Genetic aspects | Research | Hepatitis C virus | Headache | Fatigue | Infections | Nausea | Patients | Ribavirin | Studies | Cirrhosis | Sleep disorders | Genotype & phenotype | Hepatitis | Hepatitis C | Drug therapy | Genotypes | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
2003, OXFORD POLITICAL THEORY., ISBN 0198295057, 301
Book
1957, 184
Book
The New England journal of medicine, ISSN 0028-4793, 05/2013, Volume 368, Issue 20, pp. 1878 - 1887
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Viral hepatitis | Infectious diseases | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Recombinant Proteins - therapeutic use | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Polyethylene Glycols - adverse effects | Male | RNA, Viral - blood | Recombinant Proteins - adverse effects | Polyethylene Glycols - therapeutic use | Young Adult | Adult | Female | Uridine Monophosphate - adverse effects | Drug Therapy, Combination | Uridine Monophosphate - therapeutic use | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Genotype | Logistic Models | Hepatitis C, Chronic - drug therapy | Liver Cirrhosis - virology | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Aged | Interferon-alpha - adverse effects | Sofosbuvir | Antiviral agents | Complications and side effects | Causes of | Dosage and administration | Research | Hepatitis C virus | Blood diseases | Headache | Clinical trials | Chronic infection | Fatigue | Nausea | Ribavirin | Studies | Genotype & phenotype | Hepatitis | Hepatitis C | Drug therapy | Drug dosages | Genotypes | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9742, pp. 705 - 716
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Proline - analogs & derivatives | Antiviral Agents - therapeutic use | Humans | Middle Aged | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Male | Recombinant Proteins | Hepatitis C, Chronic - drug therapy | Polyethylene Glycols - therapeutic use | Viral Load | Proline - therapeutic use | Adult | Female | Drug Therapy, Combination | Protease Inhibitors - therapeutic use | Viral Nonstructural Proteins - antagonists & inhibitors | Peginterferon alfa-2b | Boceprevir | Dosage and administration | Hepatitis C | Drug therapy | Ribavirin | Data collection | Hepatitis | Genotype & phenotype | Clinical medicine | Hemophilia | Committees | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 06/2017, Volume 376, Issue 22, pp. 2134 - 2146
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hepatitis C - drug therapy | Humans | Middle Aged | Drug Resistance, Viral | Hepacivirus - genetics | Male | Heterocyclic Compounds, 4 or More Rings - therapeutic use | Aged, 80 and over | Adult | Female | Hepatitis C - complications | Sofosbuvir - adverse effects | Protease Inhibitors - therapeutic use | Hepacivirus - drug effects | Sofosbuvir - therapeutic use | Liver Cirrhosis - etiology | Antiviral Agents - therapeutic use | Genotype | Heterocyclic Compounds, 4 or More Rings - adverse effects | Macrocyclic Compounds - adverse effects | Macrocyclic Compounds - therapeutic use | Sulfonamides - therapeutic use | Antiviral Agents - adverse effects | Hepatitis C - virology | Sulfonamides - adverse effects | Carbamates - adverse effects | Aged | Carbamates - therapeutic use | Viral Nonstructural Proteins - antagonists & inhibitors | Drug Combinations | Care and treatment | Hepatitis C virus | Drug therapy | Patients | Health aspects | Headache | Antiretroviral drugs | Antiviral agents | Proteinase | Clinical trials | Diarrhea | Fatigue | Nausea | Cirrhosis | Hepatitis | Genotypes | Pharmaceuticals | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology
Journal Article
The New England journal of medicine, ISSN 0028-4793, 05/2013, Volume 368, Issue 20, pp. 1867 - 1877
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Viral hepatitis | Infectious diseases | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Antiviral Agents - therapeutic use | Humans | Middle Aged | Ribavirin - therapeutic use | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Genotype | Logistic Models | Male | RNA, Viral - blood | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Young Adult | Liver Cirrhosis - virology | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Adult | Female | Aged | Uridine Monophosphate - adverse effects | Drug Therapy, Combination | Sofosbuvir | Uridine Monophosphate - therapeutic use | Antiviral agents | Care and treatment | Causes of | Dosage and administration | Research | Hepatitis C | Mental illness | Headache | Clinical trials | Chronic infection | Fatigue | Infections | Nausea | Patients | Ribavirin | Cirrhosis | Sleep disorders | Genotype & phenotype | Hepatitis | Interferon | Drug therapy | Genotypes | Index Medicus | Abridged Index Medicus
Journal Article
1984, Foundations of modern Britain., ISBN 0582489741, xiii, 479
Book
Hepatology (Baltimore, Md.), ISSN 0270-9139, 08/2017, Volume 66, Issue 2, pp. 389 - 397
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Confidence Intervals | Follow-Up Studies | United States | Humans | Middle Aged | Hepacivirus - genetics | Male | Dose-Response Relationship, Drug | Young Adult | Time Factors | Adult | Female | Drug Therapy, Combination | Benzimidazoles - therapeutic use | Quinoxalines - therapeutic use | Liver Function Tests | Drug Administration Schedule | Administration, Oral | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Genotype | Treatment Outcome | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Retreatment | Sulfonamides - therapeutic use | Adolescent | Aged | Viral Load - drug effects | Antiretroviral drugs | Alanine | Chronic infection | Infections | Bilirubin | Ribavirin | Confidence intervals | Cirrhosis | Genotype & phenotype | Hepatitis | Hemoglobin | Alanine transaminase | Interferon | Hepatitis C | Index Medicus | Original
Journal Article